See 1 citation in The Journal Of Neuroscience 2010 by Valenza:
J Neurosci. 2010 Aug 11;30(32):10844-50. doi: 10.1523/JNEUROSCI.0917-10.
2010.
Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes.
Valenza M1,
Leoni V,
Karasinska JM,
Petricca L,
Fan J,
Carroll J,
Pouladi MA,
Fossale E,
Nguyen HP,
Riess O,
MacDonald M,
Wellington C,
DiDonato S,
Hayden M,
Cattaneo E.
- 1
- Department of Pharmacological Sciences and Centre for Stem Cell Research, Università degli Studi di Milano, 20133 Milan, Italy.
Abstract
Brain cholesterol, which is synthesized locally, is a major component of myelin and cell membranes and participates in neuronal functions, such as membrane trafficking, signal transduction, neurotransmitter release, and synaptogenesis. Here we show that brain cholesterol biosynthesis is reduced in multiple transgenic and knock-in Huntington's disease (HD) rodent models, arguably dependent on deficits in mutant astrocytes. Mice carrying a progressively increased number of CAG repeats show a more evident reduction in cholesterol biosynthesis. In postnatal life, the cholesterol-dependent activities of neurons mainly rely on the transport of cholesterol from astrocytes on ApoE-containing particles. Our data show that mRNA levels of cholesterol biosynthesis and efflux genes are severely reduced in primary HD astrocytes, along with impaired cellular production and secretion of ApoE. Consistently, in CSF of HD mice, ApoE is mostly associated with smaller lipoproteins, indicating reduced cholesterol transport on ApoE-containing lipoproteins circulating in the HD brain. These findings indicate that cholesterol defect is robustly marked in HD animals, implying that strategies aimed at selectively modulating brain cholesterol metabolism might be of therapeutic significance.
Figure 1.
Reduced brain cholesterol biosynthesis in HD rodent models. Brain lathosterol (A) and cholesterol (B) levels were progressively reduced in 10-month-old YAC46 (n = 4), YAC72 (n = 4), and YAC128 (n = 4) and increased in YAC18 (n = 4) mice compared to wt mice (n = 4). Lathosterol (C) and cholesterol (D) levels were reduced in striatum and cortex of YAC72 (n = 6) compared to wt mice (n = 6). Brain lathosterol (E) and cholesterol (F) levels were reduced in HdhQ111/111 (12 months; n = 3) compared to HdhQ7/7 (n = 5) and HdhQ7/111 (n = 5). All data were normalized above weight tissue. Graphs show mean as percentage above controls ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.
J Neurosci. 2010 Aug 11;30(32):10844-10850.
Figure 2.
Reduced brain 24OHC levels in HD rodent models. At the corresponding symptomatic stage, R6/2 (13 weeks; n = 3), YAC (10 months; n = 4 per group), HdhQ7/111 (12 months; n = 5), and HdhQ111/111 mice (12 months; n = 3) and HD rats (21 months; n = 3) showed reduced brain 24OHC levels compared to their controls. All data were normalized above weight tissue. Graph shows mean as percentage above controls ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.
J Neurosci. 2010 Aug 11;30(32):10844-10850.
Figure 3.
Decreased sterol content in R6/2 synaptosomes and myelin. A, B, Representative Western blot in myelin and synaptosome fractions against MBP (A) and SNAP25 (B), markers of myelin and synaptosomes, respectively. In whole brain (S1), sterols were reduced in R6/2 compared to wt mice (C, D). In myelin fraction, sterols were similar in all samples at 6 weeks of age (C) but were reduced at 12 weeks of age (D) in R6/2 compared to wt samples. In synaptosome fraction, sterols were reduced already at 6 weeks (C) and then at 12 weeks of age (D) in R6/2 compared to wt samples. Data were normalized on protein content. Graphs show the mean of three experiments (per age) as percentage above respective controls ± SEM. *p < 0.05; **p < 0.01.
J Neurosci. 2010 Aug 11;30(32):10844-10850.
Figure 4.
Reduced ApoE secretion in HD astrocytes and smaller ApoE-containing lipoproteins in HD CSF. A, Hmgcr, cyp51, and 7dhcr mRNA levels were reduced in primary R6/2 astrocytes with respect to wt astrocytes. Each column represents the mean from six Real-time PCR for each of the three independent cultures of R6/2 and wt astrocytes. B–E, Hmgcr, 7dhcr, abca1, and apoE mRNA levels were reduced in primary YAC128 astrocytes and increased in primary YAC18 compared to wt astrocytes. Each column corresponds to the mean of six real-time PCR performed on each of the nine independent cultures of YAC128/YAC18/wt astrocytes. All data (A–E) were normalized on β-actin. Graphs show mean of fold change above controls ± SEM. F, G, Representative Western blots and densitometry for ApoE in whole-cell lysate (F) and in conditioned medium (G) from primary wt and YAC128 astrocytes showed reduced ApoE levels in YAC128 samples (n = 4) compared to wt samples (n = 4). Cellular α-tubulin was used to normalize variations in total cell number in measurements of secreted ApoE. Coomassie staining of the membranes corresponding to proteins in the medium (4G) was also used as loading control. Graphs show mean ± SEM. H, A representative Western blot for ApoE in non-denaturing conditions shows smaller ApoE-containing-lipoproteins in CSF samples from YAC128 mice (HD; n = 2) compared to wt samples (n = 2), as indicated by arrows. Four of six CSF samples from individual YAC128 mice analyzed showed smaller ApoE-containing-lipoproteins compared to the same number of wt mice. *p < 0.05; **p < 0.01; ***p < 0.001.
J Neurosci. 2010 Aug 11;30(32):10844-10850.
Publication types
MeSH terms
Substances
Grant support
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous